BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20609109)

  • 1. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
    Bhaskar K; Hobbs GA; Yen SH; Lee G
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):462-77. PubMed ID: 20609109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of tau by fyn: implications for Alzheimer's disease.
    Lee G; Thangavel R; Sharma VM; Litersky JM; Bhaskar K; Fang SM; Do LH; Andreadis A; Van Hoesen G; Ksiezak-Reding H
    J Neurosci; 2004 Mar; 24(9):2304-12. PubMed ID: 14999081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
    Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new paradigm for regulation of protein phosphatase 2A function via Src and Fyn kinase-mediated tyrosine phosphorylation.
    Sontag JM; Schuhmacher D; Taleski G; Jordan A; Khan S; Hoffman A; Gomez RJ; Mazalouskas MD; Hanks SK; Spiller BW; Sontag E; Wadzinski BE
    J Biol Chem; 2022 Aug; 298(8):102248. PubMed ID: 35820485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microtubule-associated protein tau is also phosphorylated on tyrosine.
    Lebouvier T; Scales TM; Williamson R; Noble W; Duyckaerts C; Hanger DP; Reynolds CH; Anderton BH; Derkinderen P
    J Alzheimers Dis; 2009; 18(1):1-9. PubMed ID: 19542604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
    Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
    J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fyn depletion ameliorates tau
    Liu G; Fiock KL; Levites Y; Golde TE; Hefti MM; Lee G
    Acta Neuropathol Commun; 2020 Jul; 8(1):108. PubMed ID: 32665013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
    Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
    J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-related modifications in tau affect the interaction between Fyn and Tau.
    Bhaskar K; Yen SH; Lee G
    J Biol Chem; 2005 Oct; 280(42):35119-25. PubMed ID: 16115884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
    Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
    Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau interacts with src-family non-receptor tyrosine kinases.
    Lee G; Newman ST; Gard DL; Band H; Panchamoorthy G
    J Cell Sci; 1998 Nov; 111 ( Pt 21)():3167-77. PubMed ID: 9763511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.
    Li C; Götz J
    J Alzheimers Dis; 2018; 64(1):205-221. PubMed ID: 29782321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice.
    Köhler C; Dinekov M; Götz J
    Neurobiol Aging; 2013 May; 34(5):1369-79. PubMed ID: 23294633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
    Köhler C; Fuhr V; Dinekov M
    Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
    Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
    J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.
    Asai H; Ikezu S; Woodbury ME; Yonemoto GM; Cui L; Ikezu T
    Am J Pathol; 2014 Mar; 184(3):808-18. PubMed ID: 24418258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.